Any feedback?
Literature summary for 3.4.14.5 extracted from
- Remediation of undesirable secondary interactions encountered in hydrophilic interaction chromatography during development of a quantitative LC-MS/MS assay for a dipeptidyl peptidase IV (DPP-IV) inhibitor in monkey serum (2009), J. Chromatogr. B, 877, 471-476.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| PF-00734200 | i.e. 3,3-(difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, inhibitor of dipeptidyl peptidase IV for the treatment of diabetic complications and other disorders | Macaca fascicularis |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Macaca fascicularis | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| serum | - |
Macaca fascicularis | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| dipeptidyl peptidase IV | - |
Macaca fascicularis |
| DPP-IV | - |
Macaca fascicularis |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
